学科与关键词
关键词
childhood acute myeloid leukemiaminimal residual disease by flow-cytometryoutcome
- Childhood AML Combined with AML1-ETO Fusion Gene and c-KIT or Other Mutations Had Favorable Survival Treated By the C-Huanan AML 2015 Protocol: Study in Multicenter of South of ChinaFeng, Xiaoqin; Li, Chunfu; Li, Jian; Zheng, Yongzhi; Zheng, Mincui; Mai, Huirong; Yang, Lihua; He, Xiangling; He, Yingyi; Wen, Hong; Li, Yirong65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Dynamic Assessment of Measurable Residual Disease in Favorable-Risk Acute Myeloid Leukemia in First Remission, Treatment, and OutcomesYu, Sijian, Sr.; Liu, Qifa63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, 2021-12-11 To 2021-12-14.
- The Impact of CD19 Expression Combined with Measurable Residual Disease on Post-Remission Treatment and Outcome in Adult t(8;21) Acute Myeloid LeukemiaShi, Pengcheng; Liao, Naying; Wu, Ning; Li, Huan; Huang, Fen; Xu, Na; Fan, Zhiping; Zhang, Yu; Liu, Qifa63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, 2021-12-11 To 2021-12-14.
